世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界と中国の医療用バイオマーカーの市場規模、現状、予測2021-2027年


Global and China Medical Biomarkers Market Size, Status and Forecast 2021-2027

市場分析と洞察。医療用バイオマーカーの世界市場 メディカルバイオマーカーの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されています。 ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年12月3日 US$3,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析と洞察。医療用バイオマーカーの世界市場
メディカルバイオマーカーの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の医療用バイオマーカー市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができます。その中には、収益面でのメディカルバイオマーカー世界市場の全体的なサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の医療用バイオマーカー市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の医療用バイオマーカー市場を詳細に調査するために、独自の、そして業界で最も優れた調査・分析手法を用いています。

世界の医療用バイオマーカーの範囲と市場規模
メディカルバイオマーカー市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のメディカルバイオマーカー市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
敗血症バイオマーカー
抗生物質耐性バイオマーカー
外傷性脳損傷(TBI)検査バイオマーカー
脳卒中検査バイオマーカー
抗生物質スチュワードシップ・バイオマーカー
その他

用途別セグメント
診断
創薬
個別化医療
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
サーモフィッシャーサイエンティフィック
メルク
バイオ・ラッド・ラボラトリーズ
QIAGEN
ロシュ
ダナハー・コーポレーション
シーメンスヘルスケア
アボット
アジレント・テクノロジー


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Medical Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Medical Biomarkers Market Perspective (2016-2027)
2.2 Medical Biomarkers Growth Trends by Regions
2.2.1 Medical Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Medical Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Medical Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Medical Biomarkers Industry Dynamic
2.3.1 Medical Biomarkers Market Trends
2.3.2 Medical Biomarkers Market Drivers
2.3.3 Medical Biomarkers Market Challenges
2.3.4 Medical Biomarkers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Medical Biomarkers Players by Revenue
3.1.1 Global Top Medical Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Medical Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Medical Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Medical Biomarkers Revenue
3.4 Global Medical Biomarkers Market Concentration Ratio
3.4.1 Global Medical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Biomarkers Revenue in 2020
3.5 Medical Biomarkers Key Players Head office and Area Served
3.6 Key Players Medical Biomarkers Product Solution and Service
3.7 Date of Enter into Medical Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Medical Biomarkers Breakdown Data by Type
4.1 Global Medical Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Medical Biomarkers Forecasted Market Size by Type (2022-2027)

5 Medical Biomarkers Breakdown Data by Application
5.1 Global Medical Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Medical Biomarkers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Medical Biomarkers Market Size (2016-2027)
6.2 North America Medical Biomarkers Market Size by Type
6.2.1 North America Medical Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Medical Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Medical Biomarkers Market Size by Type (2016-2027)
6.3 North America Medical Biomarkers Market Size by Application
6.3.1 North America Medical Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Medical Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Medical Biomarkers Market Size by Application (2016-2027)
6.4 North America Medical Biomarkers Market Size by Country
6.4.1 North America Medical Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Medical Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Medical Biomarkers Market Size (2016-2027)
7.2 Europe Medical Biomarkers Market Size by Type
7.2.1 Europe Medical Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Medical Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Medical Biomarkers Market Size by Type (2016-2027)
7.3 Europe Medical Biomarkers Market Size by Application
7.3.1 Europe Medical Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Medical Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Medical Biomarkers Market Size by Application (2016-2027)
7.4 Europe Medical Biomarkers Market Size by Country
7.4.1 Europe Medical Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Medical Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Medical Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Medical Biomarkers Market Size by Type
8.2.1 Asia-Pacific Medical Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Medical Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Medical Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Medical Biomarkers Market Size by Application
8.3.1 Asia-Pacific Medical Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Medical Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Medical Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Medical Biomarkers Market Size by Region
8.4.1 Asia-Pacific Medical Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Medical Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Medical Biomarkers Market Size (2016-2027)
9.2 Latin America Medical Biomarkers Market Size by Type
9.2.1 Latin America Medical Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Medical Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Medical Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Medical Biomarkers Market Size by Application
9.3.1 Latin America Medical Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Medical Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Medical Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Medical Biomarkers Market Size by Country
9.4.1 Latin America Medical Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Medical Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Medical Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Medical Biomarkers Market Size by Type
10.2.1 Middle East & Africa Medical Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Medical Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Medical Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Medical Biomarkers Market Size by Application
10.3.1 Middle East & Africa Medical Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Medical Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Medical Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Medical Biomarkers Market Size by Country
10.4.1 Middle East & Africa Medical Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Medical Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Medical Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Medical Biomarkers Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Medical Biomarkers Introduction
11.2.4 Merck Revenue in Medical Biomarkers Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Medical Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Medical Biomarkers Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Medical Biomarkers Introduction
11.4.4 QIAGEN Revenue in Medical Biomarkers Business (2016-2021)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Medical Biomarkers Introduction
11.5.4 Roche Revenue in Medical Biomarkers Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Medical Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Medical Biomarkers Business (2016-2021)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Medical Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Medical Biomarkers Business (2016-2021)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Medical Biomarkers Introduction
11.8.4 Abbott Revenue in Medical Biomarkers Business (2016-2021)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Medical Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Medical Biomarkers Business (2016-2021)
11.9.5 Agilent Technologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Medical Biomarkers Market
The global Medical Biomarkers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medical Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medical Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medical Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medical Biomarkers market.

Global Medical Biomarkers Scope and Market Size
Medical Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other

Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Medical Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Medical Biomarkers Market Perspective (2016-2027)
2.2 Medical Biomarkers Growth Trends by Regions
2.2.1 Medical Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Medical Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Medical Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Medical Biomarkers Industry Dynamic
2.3.1 Medical Biomarkers Market Trends
2.3.2 Medical Biomarkers Market Drivers
2.3.3 Medical Biomarkers Market Challenges
2.3.4 Medical Biomarkers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Medical Biomarkers Players by Revenue
3.1.1 Global Top Medical Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Medical Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Medical Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Medical Biomarkers Revenue
3.4 Global Medical Biomarkers Market Concentration Ratio
3.4.1 Global Medical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Biomarkers Revenue in 2020
3.5 Medical Biomarkers Key Players Head office and Area Served
3.6 Key Players Medical Biomarkers Product Solution and Service
3.7 Date of Enter into Medical Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Medical Biomarkers Breakdown Data by Type
4.1 Global Medical Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Medical Biomarkers Forecasted Market Size by Type (2022-2027)

5 Medical Biomarkers Breakdown Data by Application
5.1 Global Medical Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Medical Biomarkers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Medical Biomarkers Market Size (2016-2027)
6.2 North America Medical Biomarkers Market Size by Type
6.2.1 North America Medical Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Medical Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Medical Biomarkers Market Size by Type (2016-2027)
6.3 North America Medical Biomarkers Market Size by Application
6.3.1 North America Medical Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Medical Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Medical Biomarkers Market Size by Application (2016-2027)
6.4 North America Medical Biomarkers Market Size by Country
6.4.1 North America Medical Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Medical Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Medical Biomarkers Market Size (2016-2027)
7.2 Europe Medical Biomarkers Market Size by Type
7.2.1 Europe Medical Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Medical Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Medical Biomarkers Market Size by Type (2016-2027)
7.3 Europe Medical Biomarkers Market Size by Application
7.3.1 Europe Medical Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Medical Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Medical Biomarkers Market Size by Application (2016-2027)
7.4 Europe Medical Biomarkers Market Size by Country
7.4.1 Europe Medical Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Medical Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Medical Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Medical Biomarkers Market Size by Type
8.2.1 Asia-Pacific Medical Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Medical Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Medical Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Medical Biomarkers Market Size by Application
8.3.1 Asia-Pacific Medical Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Medical Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Medical Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Medical Biomarkers Market Size by Region
8.4.1 Asia-Pacific Medical Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Medical Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Medical Biomarkers Market Size (2016-2027)
9.2 Latin America Medical Biomarkers Market Size by Type
9.2.1 Latin America Medical Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Medical Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Medical Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Medical Biomarkers Market Size by Application
9.3.1 Latin America Medical Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Medical Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Medical Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Medical Biomarkers Market Size by Country
9.4.1 Latin America Medical Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Medical Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Medical Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Medical Biomarkers Market Size by Type
10.2.1 Middle East & Africa Medical Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Medical Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Medical Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Medical Biomarkers Market Size by Application
10.3.1 Middle East & Africa Medical Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Medical Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Medical Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Medical Biomarkers Market Size by Country
10.4.1 Middle East & Africa Medical Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Medical Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Medical Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Medical Biomarkers Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Medical Biomarkers Introduction
11.2.4 Merck Revenue in Medical Biomarkers Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Medical Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Medical Biomarkers Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Medical Biomarkers Introduction
11.4.4 QIAGEN Revenue in Medical Biomarkers Business (2016-2021)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Medical Biomarkers Introduction
11.5.4 Roche Revenue in Medical Biomarkers Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Medical Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Medical Biomarkers Business (2016-2021)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Medical Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Medical Biomarkers Business (2016-2021)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Medical Biomarkers Introduction
11.8.4 Abbott Revenue in Medical Biomarkers Business (2016-2021)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Medical Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Medical Biomarkers Business (2016-2021)
11.9.5 Agilent Technologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(biomarkers market)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20 10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る